[ Price : $8.95]
Braeburn says its Brixadi treatment for opioid use disorder is available to be marketed 12/1/20 after FDA revoked the orphan drug ...[ Price : $8.95]
FDA issues a guidance explaining the process to seek review of a Certificate to Foreign Government denial.[ Price : $8.95]
Ropes & Gray says the Supreme Court will consider whether the SEC has the legal authority to seek disgorgement as an enforcement t...[ Price : $8.95]
GlaxoSmithKline says it will seek approval for Nucala (mepolizumab) for treating patients living with Hypereosinophilic Syndrome b...[ Price : $8.95]
Federal Register notice: FDA announces a 12/6 public workshop on incorporating clinical outcome assessments into endpoints for reg...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension for Product Jurisdiction: Assignment of Agency Compo...[ Price : $8.95]
FDA warns Mylan about significant deviations from CGMP requirements for active pharmaceutical ingredients at its Unit 8 in India.